Skip to main content
SpringerLink
Log in

Prostate Disease in the Aging Male

  • Chapter
Prevention and Treatment of Age-related Diseases

  • 1044 Accesses

Abstract

Prostate cancer is commonly found in older men. Whether its presence is clinically significant, requiring screening or treatment has been intensely debated, fueled by the indolent nature of many cancers as well as the competing cardiovascular mortality of this age group. Risk factors include age, race and family history. Diet has been linked to prostate cancer risk and is being investigated both for understanding the pathogenesis of prostate cancer and for use in supplements in preventing prostate cancer. In the past two decades the advent of serum marker, Prostate Specific Antigen [PSA], and definitions of pre- neoplastic lesions have brought new understandings and questions to the etiology and epidemiology of prostate cancer. This chapter will focus on the function of the prostate, pathological definitions and grading, PSA and its role in the debate, epidemiology and risk factors of prostate cancer. Current treatments and prevention trials will be reviewed

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albanes, D., et al. (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst, 88(21): 1560–70.

    PubMed  CAS  Google Scholar 

  • Albertsen, P.C., et al. (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. Jama, 280(11): 975–80.

    PubMed  CAS  Google Scholar 

  • Albertsen, P.C., Hanley, J.A. and Fine, J. (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. Jama, 293(17): 2095–101.

    PubMed  CAS  Google Scholar 

  • Allen, E.A., Kahane, H. and Epstein, J.I. (1998) Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology, 52(5): 803–7.

    PubMed  CAS  Google Scholar 

  • Allen, D.J., et al. (2004) Does body-coil magnetic-resonance imaging have a role in the preoperative staging of patients with clinically localized prostate cancer? BJU Int, 94(4): 534–8.

    PubMed  Google Scholar 

  • Andriole, G., et al. (2004) Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol, 172(4 Pt 1): 1314–7.

    PubMed  CAS  Google Scholar 

  • Andriole, G., et al. (2005) The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. J Urol, 174(6): 2098–104.

    PubMed  CAS  Google Scholar 

  • Andriole, G.L., et al. (2005) Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst, 97(6): 433–8.

    PubMed  Google Scholar 

  • Angwafo, F.F., 3rd, et al. (2003) High-grade intra-epithelial neoplasia and prostate cancer in Dibombari, Cameroon. Prostate Cancer Prostatic Dis, 6(1): 34–8.

    PubMed  Google Scholar 

  • Attar-Bashi, N.M., Frauman, A.G. and Sinclair, A.J. (2004) Alpha-linolenic acid and the risk of prostate cancer. What is the evidence? J Urol, 171(4): 1402–7.

    PubMed  Google Scholar 

  • Baade, P.D., et al. (2005) Communicating prostate cancer risk: what should we be telling our patients? Med J Aust, 182(9): 472–5.

    PubMed  Google Scholar 

  • Bartsch, G., et al. (2001) Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology, 58(3): 417–24.

    PubMed  CAS  Google Scholar 

  • Bianco, F.J., Jr., et al. (2002) Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy. J Urol, 168(2): 479–82.

    PubMed  Google Scholar 

  • Bill-Axelson, A., et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med, 352(19): 1977–84.

    PubMed  CAS  Google Scholar 

  • Borboroglu, P.G., et al. (2001) Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol, 166(3): 866–70.

    PubMed  CAS  Google Scholar 

  • Borgono, C.A. and Diamandis, E.P. (2004) The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer, 4(11): 876–90.

    PubMed  CAS  Google Scholar 

  • Boring, C.C., Squires, T.S. and Tong, T. (1992) Cancer statistics, 1992. CA Cancer J Clin, 42(1): 19–38.

    PubMed  CAS  Google Scholar 

  • Bostwick, D.G., et al. (2004) Does finasteride alter the pathology of the prostate and cancer grading? Clin Prostate Cance, 2(4): 228–35.

    CAS  Google Scholar 

  • Bostwick, D.G. (1988) Premalignant lesions of the prostate. Semin Diagn Pathol, 5(3): 240–53.

    PubMed  CAS  Google Scholar 

  • Bostwick, D.G. (1996) Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer, 78(2): 330–6.

    PubMed  CAS  Google Scholar 

  • Bostwick, D.G. and Brawer, M.K. (1987) Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer, 59(4): 788–94.

    PubMed  CAS  Google Scholar 

  • Brausi, M., et al. (2004) Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? J Urol, 172(3): 906–8; discussion 908–9.

    PubMed  Google Scholar 

  • Brawer, M.K., et al. (1991) Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology, 38(2): 103–7.

    PubMed  CAS  Google Scholar 

  • Breslow, N., et al. (1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer, 20(5): 680–8.

    PubMed  CAS  Google Scholar 

  • Carpten, J., et al. (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet, 30(2): 181–4.

    PubMed  CAS  Google Scholar 

  • Carroll, P., et al. (2001) Prostate-specific antigen best practice policy–part II: prostate cancer staging and post-treatment follow-up. Urology, 57(2): 225–9.

    PubMed  CAS  Google Scholar 

  • Carter, B.S., et al. (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol, 150(3): 797–802.

    PubMed  CAS  Google Scholar 

  • Carver, B.S., et al. (2005) Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy. BJU Int, 95(4): 509–12.

    PubMed  Google Scholar 

  • Catalona, W.J., et al. (1994) Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol, 152(6 Pt 1): 2031–6.

    PubMed  CAS  Google Scholar 

  • Catalona, W.J., et al. (2004) Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen. J Urol, 171(6 Pt 1): 2239–44.

    PubMed  Google Scholar 

  • Chan, T.Y. and Epstein, J.I. (1999) Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology, 53(2): 351–5.

    PubMed  CAS  Google Scholar 

  • Chan, D.W., et al. (1987) Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Clin Chem, 33(10): 1916–20.

    PubMed  CAS  Google Scholar 

  • Chan, J.M., et al. (2001) Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. Am J Clin Nutr, 74(4): 549–54.

    PubMed  CAS  Google Scholar 

  • Chan, J.M., Gann, P.H. and Giovannucci, E.L. (2005) Role of diet in prostate cancer development and progression. J Clin Oncol, 23(32): 8152–60.

    PubMed  CAS  Google Scholar 

  • Cheville, J.C., Reznicek, M.J. and Bostwick, D.G. (1997) The focus of “atypical glands, suspicious for malignancy” in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol, 108(6): 633–40.

    PubMed  CAS  Google Scholar 

  • Christen, W.G., Gaziano, J.M. and Hennekens, C.H. (2000) Design of Physicians’ Health Study II–a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol, 10(2): 125–34.

    PubMed  CAS  Google Scholar 

  • Clark, L.C., et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Jama, 276(24): 1957–63.

    PubMed  CAS  Google Scholar 

  • Clark, L.C., et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 81(5): 730–4.

    PubMed  CAS  Google Scholar 

  • Cooperberg, M.R., Moul, J.W. and Carroll, P.R. (2005) The changing face of prostate cancer. J Clin Oncol, 23(32): 8146–51.

    PubMed  Google Scholar 

  • D’Amico, A.V., et al. (2004) Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy. J Urol, 172(5 Pt 2): S42–6; discussion S46–7.

    PubMed  Google Scholar 

  • D’Amico, A.V., et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med, 351(2): 125–35.

    PubMed  CAS  Google Scholar 

  • Dagnelie, P.C., et al. (2004) Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int, 93(8): 1139–50.

    PubMed  CAS  Google Scholar 

  • Danley, K.L., et al. (1995) Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States). Cancer Causes Control, 6(6): 492–8.

    PubMed  CAS  Google Scholar 

  • Davidson, D., et al. (1995) Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol, 154(4): 1295–9.

    PubMed  CAS  Google Scholar 

  • Dhom, G. (1983) Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate. J Cancer Res Clin Oncol, 106(3): 210–8.

    PubMed  CAS  Google Scholar 

  • Diblasio, C.J. and Kattan, M.W. (2003) Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer. Urology, 62 Suppl 1: 9–18.

    PubMed  Google Scholar 

  • Donn, A.S. and Muir, C.S. (1985) Prostatic cancer: some epidemiological features. Bull Cancer, 72(5): 381–90.

    PubMed  CAS  Google Scholar 

  • Drago, J.R., Mostofi F.K. and Lee Fred. (1989) Introductory Remarks and Workshop Summary. Urology, 34(6): 2–3.

    Google Scholar 

  • Edwards, S.M. and Eeles, R.A. (2004) Unravelling the genetics of prostate cancer. Am J Med Genet C Semin Med Genet, 129(1): 65–73.

    PubMed  Google Scholar 

  • Feneley, M.R., et al. (1997) Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications. Prostate Cancer Prostatic Dis, 1(2): 79–83.

    PubMed  Google Scholar 

  • Ferlay, J., B.F., Pisani P. and Parkin D.M. (2004) Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase. No. 5(version 2.0).

    Google Scholar 

  • Fowler, F.J., Jr., et al. (2000) Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Jama, 283(24): 3217–22.

    PubMed  Google Scholar 

  • Fowler, F.J., Jr., et al. (1995) Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology, 45(6): 1007–13; discussion 1013–5.

    PubMed  Google Scholar 

  • Fowler, F.J., Jr., et al. (1996) Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol, 14(8): 2258–65.

    PubMed  Google Scholar 

  • Fowler, J.E., Jr., et al. (2000) Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol, 163(3): 813–8.

    PubMed  Google Scholar 

  • Giovannucci, E.L., et al. (2005) A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med, 165(9): 1005–10.

    PubMed  Google Scholar 

  • Giovannucci, E. (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control, 16(2): 83–95.

    PubMed  Google Scholar 

  • Gleason, D.F. (1966) Classification of prostatic carcinomas. Cancer Chemother Rep, 50(3): 125–8.

    PubMed  CAS  Google Scholar 

  • Glover, F.E., Jr., et al. (1998) The epidemiology of prostate cancer in Jamaica. J Urol, 159(6): 1984–6; discussion 1986–7.

    PubMed  Google Scholar 

  • Gokden, N., et al. (2005) High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology, 65(3): 538–42.

    PubMed  Google Scholar 

  • Goode, E.L., Ulrich, C.M. and Potter, J.D. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11(12): 1513–30.

    PubMed  CAS  Google Scholar 

  • Grignon, D.J. and Sakr, W.A. (1996) Atypical adenomatous hyperplasia of the prostate: a critical review. Eur Urol, 30(2): 206–11.

    PubMed  CAS  Google Scholar 

  • Gsur, A., Feik, E. and Madersbacher, S. (2004) Genetic polymorphisms and prostate cancer risk. World J Urol, 21(6): 414–23.

    PubMed  CAS  Google Scholar 

  • Habel, L.A., Zhao, W. and Stanford, J.L. (2002) Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control, 13(5): 427–34.

    PubMed  Google Scholar 

  • Han, M., et al. (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am, 28(3): 555–65.

    CAS  Google Scholar 

  • Hebert, J.R., et al. (1998) Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst, 90(21): 1637–47.

    PubMed  CAS  Google Scholar 

  • Helpap, B.G., Bostwick, D.G. and Montironi, R. (1995) The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update. Virchows Arch, 426(5): 425–34.

    CAS  Google Scholar 

  • Hoedemaeker, R.F., et al. (1997) Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer. World J Urol, 15(6): 339–45.

    PubMed  CAS  Google Scholar 

  • Holmberg, L., et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med, 347(11): 781–9.

    PubMed  Google Scholar 

  • Horninger, W., et al. (2005) Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol, 12 Suppl 1: 7–13; discussion 92–3.

    PubMed  Google Scholar 

  • Hugosson, J., Aus, G. and Norlen, L. (1996) Surveillance is not a viable and appropriate treatment option in the management of localized prostate cancer. Urol Clin North Am, 23(4): 557–73.

    PubMed  CAS  Google Scholar 

  • Iczkowski, K.A., MacLennan, G.T. and Bostwick, D.G. (1997) Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol, 21(12): 1489–95.

    PubMed  CAS  Google Scholar 

  • Iczkowski, K.A., et al. (1998) Diagnosis of “suspicious for malignancy” in prostate biopsies: predictive value for cancer. Urology, 51(5): 749–57; discussion 757–8.

    PubMed  CAS  Google Scholar 

  • Jackson, M.A., et al. (1980) Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC. Prostate, 1(2): 185–205.

    PubMed  CAS  Google Scholar 

  • Jackson, M.A., et al. (1981) Factors involved in the high incidence of prostatic cancer among American blacks. Prog Clin Biol Res, 53: 111–32.

    PubMed  CAS  Google Scholar 

  • Jemal, A., et al. (2005) Cancer statistics, 2005. CA Cancer J Clin, 55(1): 10–30.

    PubMed  Google Scholar 

  • Johns, L.E. and Houlston, R.S. (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int, 91(9): 789–94.

    PubMed  CAS  Google Scholar 

  • Kattan, M.W., et al. (2003) Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol, 170(5): 1792–7.

    PubMed  Google Scholar 

  • Khan, M.A., et al. (2003) Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology, 62(1): 86–91; discussion 91–2.

    PubMed  Google Scholar 

  • Klotz, L. (2005) Active surveillance for prostate cancer: for whom? J Clin Oncol, 23(32): 8165–9.

    PubMed  Google Scholar 

  • Kristal, A.R., et al. (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 11(8): 719–25.

    PubMed  CAS  Google Scholar 

  • Kronz, J.D., et al. (2001) Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol, 25(8): 1079–85.

    PubMed  CAS  Google Scholar 

  • Kuller, L.H., et al. (2004) Elevated prostate-specific antigen levels up to 25 years prior to death from prostate cancer. Cancer Epidemiol Biomarkers Prev, 13(3): 373–7.

    PubMed  Google Scholar 

  • Kundu, S.D., et al. (2004) Potency, Continence And Complications In 3,477 Consecutive Radical Retropubic Prostatectomies. J Urol, 172(6, Part 1 of 2): 2227–2231.

    PubMed  Google Scholar 

  • Labrie, F., et al. (1999) Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate, 38(2): 83–91.

    PubMed  CAS  Google Scholar 

  • Labrie, F., et al. (2004) Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial. Prostate, 59(3): 311–8.

    PubMed  Google Scholar 

  • Latil, A.G., et al. (2001) Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer, 92(5): 1130–7.

    PubMed  CAS  Google Scholar 

  • Lee, M.M., et al. (1998) Case-control study of diet and prostate cancer in China. Cancer Causes Control, 9(6): 545–52.

    PubMed  CAS  Google Scholar 

  • Lefkowitz, G.K., et al. (2001) Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology, 58(6): 999–1003.

    PubMed  CAS  Google Scholar 

  • Lefkowitz, G.K., et al. (2002) Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol, 168(4 Pt 1): 1415–8.

    PubMed  Google Scholar 

  • Leitzmann, M.F., et al. (2004) Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr, 80(1): 204–16.

    PubMed  CAS  Google Scholar 

  • Li, H., et al. (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst, 96(9): 696–703.

    PubMed  CAS  Google Scholar 

  • Li, H., et al. (2005) Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res, 65(6): 2498–504.

    PubMed  CAS  Google Scholar 

  • Lin, D.D., et al. (2005) Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era. Urology, 65(3): 528–32.

    PubMed  Google Scholar 

  • Lippman, S.M., et al. (2005) Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst, 97(2): 94–102.

    PubMed  CAS  Google Scholar 

  • Luo, J., et al. (2003) Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma. Prostate, 57(2): 134–9.

    PubMed  CAS  Google Scholar 

  • Lu-Yao, G.L. and Yao, S.L. (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet, 349(9056): 906–10.

    PubMed  CAS  Google Scholar 

  • Mallick, S., Blanchet, P. and Multigner, L. (2005) Prostate cancer incidence in guadeloupe, a French Caribbean archipelago. Eur Urol, 47(6): 769–72.

    PubMed  Google Scholar 

  • Mann, T. (1974) Secretory function of the prostate, seminal vesicle and other male accessory organs of reproduction. J Reprod Fertil, 37(1): 179–88.

    PubMed  CAS  Google Scholar 

  • Marker, P.C., et al. (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol, 253(2): 165–74.

    PubMed  CAS  Google Scholar 

  • McNeal, J.E. (1981) The zonal anatomy of the prostate. Prostate, 2(1): 35–49.

    PubMed  CAS  Google Scholar 

  • McNeal, J.E. and Bostwick, D.G. (1986) Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol, 17(1): 64–71.

    PubMed  CAS  Google Scholar 

  • Merck VIOXX Timeline, in http://media.corporateir.net/media_files/irol/73/73184/VIOXX_Timeline.pdf.(2004).

    Google Scholar 

  • Messing, E.M., et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med, 341(24): 1781–8.

    PubMed  CAS  Google Scholar 

  • Messing, E. (2003) The timing of hormone therapy for men with asymptomatic advanced prostate cancer. Urol Oncol, 21(4): 245–54.

    PubMed  CAS  Google Scholar 

  • Mian, B.M., et al. (2002) Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology, 60(5): 836–40.

    PubMed  Google Scholar 

  • Mikolajczyk, S.D. and Rittenhouse, H.G. (2004) Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease. Rinsho Byori, 52(3): 223–30.

    PubMed  CAS  Google Scholar 

  • Montironi, R., et al. (2004) Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia. Mod Pathol, 17(8): 928–37.

    PubMed  Google Scholar 

  • Montironi, R., et al. (2005) Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol, 36(6): 646–54.

    PubMed  Google Scholar 

  • Moore, C.K., et al. (2005) Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol, 173(1): 70–2.

    PubMed  Google Scholar 

  • Muir, C.S., Nectoux, J. and Staszewski, J. (1991) The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol, 30(2): 133–40.

    CAS  Google Scholar 

  • Nakayama, M., et al. (2004) GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem, 91(3): 540–52.

    PubMed  CAS  Google Scholar 

  • Narain, V., et al. (2001) How accurately does prostate biopsy Gleason score predict pathologic findings and disease free survival? Prostate, 49(3): 185–90.

    PubMed  CAS  Google Scholar 

  • Nelson, W.G., et al. (2004) The role of inflammation in the pathogenesis of prostate cancer. J Urol, 172(5 Pt 2): S6–11; discussion S11–2.

    PubMed  CAS  Google Scholar 

  • Nguyen, E.V. (2003) Cancer in Asian American males: epidemiology, causes, prevention, and early detection. Asian Am Pac Isl J Health, 10(2): 86–99.

    PubMed  Google Scholar 

  • Orozco, R., et al. (1998) Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology, 51(2): 186–95.

    PubMed  CAS  Google Scholar 

  • Ostrander, E.A., Markianos, K. and Stanford, J.L. (2004) Finding prostate cancer susceptibility genes. Annu Rev Genomics Hum Genet, 5: 151–75.

    PubMed  CAS  Google Scholar 

  • Palapattu, G.S., et al. (2005) Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis, 26(7): 1170–81.

    PubMed  CAS  Google Scholar 

  • Pan, C.X., et al. (2004) PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res, 10(4): 1333–7.

    PubMed  CAS  Google Scholar 

  • Pareek, G. and Nakada, S.Y. (2005) The current role of cryotherapy for renal and prostate tumors. Urol Oncol, 23(5): 361–6.

    PubMed  Google Scholar 

  • Partin, A.W. and Carter, H.B. (1996) The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer. Urol Clin North Am, 23(4): 531–40.

    PubMed  CAS  Google Scholar 

  • Partin, A.W., et al. (1993) The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol, 150(1): 110–4.

    PubMed  CAS  Google Scholar 

  • Partin, A.W., et al. (1997) Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi- institutional update. Jama, 277(18): 1445–51.

    CAS  Google Scholar 

  • Partin, A.W., et al. (2001) Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology, 58(6): 843–8.

    PubMed  CAS  Google Scholar 

  • Petros, J.A., et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA, 102(3): 719–24.

    PubMed  CAS  Google Scholar 

  • Plaskon, L.A., et al. (2003) Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomarkers Prev, 12(7): 604–9.

    PubMed  CAS  Google Scholar 

  • Platz, E.A., De Marzo, A.M. and Giovannucci, E. (2004) Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem, 91(3): 553–71.

    PubMed  CAS  Google Scholar 

  • Platz, E.A., et al. (2005) Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging. Cancer Epidemiol Biomarkers Prev, 14(2): 390–6.

    PubMed  CAS  Google Scholar 

  • Postma, R., et al. (2004) Lesions predictive for prostate cancer in a screened population: first and second screening round findings. Prostate, 61(3): 260–6.

    PubMed  Google Scholar 

  • Potosky, A.L., et al. (2004) Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst, 96(18): 1358–67.

    PubMed  Google Scholar 

  • Pound, C.R., et al. (1997) Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am, 24(2): 395–406.

    CAS  Google Scholar 

  • Pound, C.R., et al. (1999) Natural history of progression after PSA elevation following radical prostatectomy. Jama, 281(17): 1591–7.

    PubMed  CAS  Google Scholar 

  • Prentice, R.L. and Sheppard, L. (1990) Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control, 1(1): 81–97; discussion 99–109.

    PubMed  CAS  Google Scholar 

  • Pu, Y.S., et al. (2004) Changing trends of prostate cancer in Asia. Aging Male, 7(2): 120–32.

    PubMed  CAS  Google Scholar 

  • Qian, J., Jenkins, R.B. and Bostwick, D.G. (1998) Determination of gene and chromosome dosage in prostatic intraepithelial neoplasia and carcinoma. Anal Quant Cytol Histol, 20(5): 373–80.

    PubMed  CAS  Google Scholar 

  • Qian, J., Jenkins, R.B. and Bostwick, D.G. (1999) Genetic and chromosomal alterations in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Eur Urol, 35(5–6): 479–83.

    PubMed  CAS  Google Scholar 

  • Raviv, G., et al. (1996) Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol, 156(3): 1050–4; discussion 1054–5.

    PubMed  CAS  Google Scholar 

  • Rebbeck, T.R., et al. (1998) Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst, 90(16): 1225–9.

    PubMed  CAS  Google Scholar 

  • Rishi, I., et al. (2003) Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl Immunohistochem Mol Morphol, 11(3): 253–60.

    PubMed  CAS  Google Scholar 

  • Roehl, K.A., et al. (2004) Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol, 172(3): 910–4.

    PubMed  Google Scholar 

  • Rose, D.P., Boyar, A.P. and Wynder, E.L. (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58(11): 2363–71.

    PubMed  CAS  Google Scholar 

  • Rubin, M.A., et al. (2005) Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. Urology, 66(5): 930–4.

    PubMed  Google Scholar 

  • Ryan, C.J. and Eisenberger, M. (2005) Chemotherapy for hormone-refractory prostate cancer: now it’s a question of “when?”. J Clin Oncol, 23(32): 8242–6.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A. and Grignon, D.J. (1998) Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate. Anal Quant Cytol Histol, 20(5): 417–23.

    CAS  Google Scholar 

  • Sakr, W.A. and Partin, A.W. (2001) Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology, 57(4 Suppl 1): 115–20.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A., et al. (1993) The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol, 150(2 Pt 1): 379–85.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A., et al. (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases. In Vivo, 8(3): 439–43.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A., et al. (1996) Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol, 30(2): 138–44.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A., et al. (2000) Epidemiology and molecular biology of early prostatic neoplasia. Mol Urol, 4(3): 109–13; discussion 115.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A. (1999) Prostatic intraepithelial neoplasia: A marker for high-risk groups and a potential target for chemoprevention. Eur Urol, 35(5–6): 474–8.

    PubMed  CAS  Google Scholar 

  • Sakr, W.A. (2004) Epidemiology of prostate cancer and its precursors. Mod Pathol.

    Google Scholar 

  • San Francisco, I.F., et al. (2003) Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int, 91(4): 350–4.

    PubMed  CAS  Google Scholar 

  • Sanchez-Chapado, M., et al. (2003) Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate, 54(3): 238–47.

    PubMed  Google Scholar 

  • Sandblom, G., et al. (2004) Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol, 46(6): 717–23; discussion 724.

    PubMed  Google Scholar 

  • Schoonen, W.M., et al. (2005) Alcohol consumption and risk of prostate cancer in middle-aged men. Int J Cancer, 113(1): 133–40.

    PubMed  CAS  Google Scholar 

  • Sim, H.G. and Cheng C.W. (2005) Changing demography of prostate cancer in Asia. Eur J Cancer, 41(6): 834–45.

    PubMed  Google Scholar 

  • Sinha, A.A., et al. (2004) Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Exp Mol Pathol, 77(2): 153–9.

    PubMed  CAS  Google Scholar 

  • Smith, R.A., Cokkinides, V. and Eyre, H.J. (2005) American Cancer Society Guidelines for the Early Detection of Cancer. CA Cancer J Clin, 2005, 55(1): 31–44; quiz 55–6.

    Google Scholar 

  • Smith, J.A., Jr. and Herrell, S.D. (2005) Robotic-assisted laparoscopic prostatectomy: do minimally invasive approaches offer significant advantages? J Clin Oncol, 23(32): 8170–5.

    PubMed  Google Scholar 

  • Speight, J.L. and Roach, M. (2005) 3rd, Radiotherapy in the management of clinically localized prostate cancer: evolving standards, consensus, controversies and new directions. J Clin Oncol, 23(32): 8176–85.

    PubMed  Google Scholar 

  • Steiner, M.S. and Pound, C.R. (2003) Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia. Clin Prostate Cancer, 2(1): 24–31.

    PubMed  CAS  Google Scholar 

  • Steiner, M.S., B.R., Barnette G., et al. (2004) Evaluation of Acapodene in reducing prostate cancer incidence in high risk men. in Third Annual AACR Frontiers in Cancer Prevention Research.Seattle, WA.

    Google Scholar 

  • Steiner, M.S. (2003) High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction. World J Urol, 21(1): 15–20.

    PubMed  Google Scholar 

  • Stratton, M.S., et al. (2003) Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anticancer Drugs, 14(8): 589–94.

    PubMed  CAS  Google Scholar 

  • Taylor, S.H., et al. (2005) Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer. Cancer.

    Google Scholar 

  • Thomas, L.N., et al. (2003) 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium. J Urol, 170(5): 2019–25.

    PubMed  CAS  Google Scholar 

  • Thompson, I.M., et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med, 350(22): 2239–46.

    PubMed  CAS  Google Scholar 

  • van der Cruijsen-Koeter, I.W., et al. (2005) Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam. J Urol, 174(1): 121–5.

    PubMed  Google Scholar 

  • van der Kwast, T.H., et al. (2003) Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol, 56(5): 336–40.

    PubMed  Google Scholar 

  • Vij, U. and Kumar, A. (2004) Phyto-oestrogens and prostatic growth. Nal Med J India, 17(1): 22–6.

    Google Scholar 

  • Virtamo, J., et al. (2003) Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. Jama, 290(4): 476–85.

    PubMed  CAS  Google Scholar 

  • Visvanathan, K., et al. (2004) Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. J Urol, 171(2 Pt 1): 652–5.

    PubMed  Google Scholar 

  • Walsh, P.C., Partin, A.W. and Epstein, J.I. (1994) Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol, 152(5 Pt 2): 1831–6.

    PubMed  CAS  Google Scholar 

  • Wei, J.T., et al. (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol, 20(2): 557–66.

    PubMed  Google Scholar 

  • Weinstein, M.H. and Epstein, J.I. (1993) Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol, 24(6): 624–9.

    PubMed  CAS  Google Scholar 

  • Whittemore, A.S., et al. (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst, 87(9): 652–61.

    Google Scholar 

  • Wills, M.L., et al. (1997) Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology, 49(3): 367–73.

    PubMed  CAS  Google Scholar 

  • Wilt, T.J. and Brawer, M.K. (1997) The Prostate Cancer Intervention Versus Observation Trial (PIVOT). Oncology (Williston Park), 11(8): 1133–9; discussion 1139–40, 1143.

    CAS  Google Scholar 

  • Wolf, J.S., Jr., et al. (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol, 153 (3 Pt 2): 993–9.

    PubMed  Google Scholar 

  • Wu, C.L., et al. (2004) Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol, 35(8): 1008–13.

    PubMed  CAS  Google Scholar 

  • Xu, J., et al. (2002) Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32(2): 321–5.

    PubMed  CAS  Google Scholar 

  • Yatani, R., et al. (1982) Geographic pathology of latent prostatic carcinoma. Int J Cancer, 29(6): 611–6.

    PubMed  CAS  Google Scholar 

  • Yoshizawa, K., et al. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 90(16): 1219–24.

    PubMed  CAS  Google Scholar 

  • Zaridze, D.G., Boyle, P. and Smans, M. (1984) International trends in prostatic cancer. Int J Cancer, 33(2): 223–30.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Associate Clinical Professor of Urology, University of California, Irvine, 101 The City Drive Rt 81, Orange, CA 92868

    Anne R. Simoneau

Authors
  1. Anne R. Simoneau
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Danish Centre for Molecular Gerontology, University of Aarhus, Denmark

    Suresh I.S. Rattan

  2. University Hospital of Odense, Denmark

    Moustapha Kassem

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer

About this chapter

Cite this chapter

Simoneau, A.R. (2006). Prostate Disease in the Aging Male. In: Rattan, S.I., Kassem, M. (eds) Prevention and Treatment of Age-related Diseases. Springer, Dordrecht. https://doi.org/10.1007/1-4020-5058-5_13

Download citation

Publish with us

Policies and ethics

Search

Navigation